(Total Views: 765)
Posted On: 12/13/2021 12:06:45 PM
Post# of 148884
Kevin and all invested in CYDY, here is a look at what I believe to be a dastardly success in censoring Leronlimab by those we are talking about today and lately.
Check out this link to understand more of what happened:
https://www.thegatewaypundit.com/2021/12/vide...rug-covid/
GLTU and all longs. We must stay fully invested in CYDY as it's being pummeled to death because we have something that no other bio company has and it pains them tremendously that this little company of ours has so much attention and that tells me we have a miracle monoclonal drug that all the big pharma club members wish they had instead of us.
IMO, I can't even think of selling not even 1/2 of a share of my investment in our monoclonal drug. The more they keep pushing us out of the way, it shows me how important Leronlimab really is. We just need to have the fortitude to let this play out to the very, very end. Leronlimab can't be squashed for the news will eventually come out and that is what I am waiting for even if it takes another year but again, IMO, it will be in 2022
Check out this link to understand more of what happened:
https://www.thegatewaypundit.com/2021/12/vide...rug-covid/
GLTU and all longs. We must stay fully invested in CYDY as it's being pummeled to death because we have something that no other bio company has and it pains them tremendously that this little company of ours has so much attention and that tells me we have a miracle monoclonal drug that all the big pharma club members wish they had instead of us.
IMO, I can't even think of selling not even 1/2 of a share of my investment in our monoclonal drug. The more they keep pushing us out of the way, it shows me how important Leronlimab really is. We just need to have the fortitude to let this play out to the very, very end. Leronlimab can't be squashed for the news will eventually come out and that is what I am waiting for even if it takes another year but again, IMO, it will be in 2022
(3)
(0)
Scroll down for more posts ▼